DK21184D0 - Fremgangsmade til fremstilling af human vaevsplasminogenaktivator (tpa) i vaertsceller,udtrykkelsesvektor for tpa og et dhfr-protein,celler transformeret med vektoren,og fremgangsmade til foroegelse af vaertscellernes produktion af tpa - Google Patents

Fremgangsmade til fremstilling af human vaevsplasminogenaktivator (tpa) i vaertsceller,udtrykkelsesvektor for tpa og et dhfr-protein,celler transformeret med vektoren,og fremgangsmade til foroegelse af vaertscellernes produktion af tpa

Info

Publication number
DK21184D0
DK21184D0 DK0211/84A DK21184A DK21184D0 DK 21184 D0 DK21184 D0 DK 21184D0 DK 0211/84 A DK0211/84 A DK 0211/84A DK 21184 A DK21184 A DK 21184A DK 21184 D0 DK21184 D0 DK 21184D0
Authority
DK
Denmark
Prior art keywords
tpa
vector
host cells
plasminogen activator
tissue plasminogen
Prior art date
Application number
DK0211/84A
Other languages
English (en)
Other versions
DK21184A (da
DK174081B1 (da
Inventor
Arthur David Levinson
Christian Clinton Simonsen
Elizabeth Mcleod Ylverton
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of DK21184D0 publication Critical patent/DK21184D0/da
Publication of DK21184A publication Critical patent/DK21184A/da
Application granted granted Critical
Publication of DK174081B1 publication Critical patent/DK174081B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0026—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5)
    • C12N9/0028—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5) with NAD or NADP as acceptor (1.5.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Electrotherapy Devices (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
DK198400211A 1983-01-19 1984-01-18 Fremgangsmåde til fremstilling af human vævsplasminogenaktivator (tPA) i værtsceller, ekspressionsvektorer for tPA og et DHFR-protein, rekombinante celler transformeret med vektoren, fremgangsmåde til amplifikation af DNA sekvensen,...... DK174081B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45915383A 1983-01-19 1983-01-19
US45915383 1983-01-19

Publications (3)

Publication Number Publication Date
DK21184D0 true DK21184D0 (da) 1984-01-18
DK21184A DK21184A (da) 1984-08-24
DK174081B1 DK174081B1 (da) 2002-05-27

Family

ID=23823628

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198400211A DK174081B1 (da) 1983-01-19 1984-01-18 Fremgangsmåde til fremstilling af human vævsplasminogenaktivator (tPA) i værtsceller, ekspressionsvektorer for tPA og et DHFR-protein, rekombinante celler transformeret med vektoren, fremgangsmåde til amplifikation af DNA sekvensen,......

Country Status (12)

Country Link
EP (1) EP0117059B1 (da)
JP (1) JPS59183693A (da)
KR (1) KR840007255A (da)
AT (1) ATE59410T1 (da)
AU (1) AU572108B2 (da)
CA (1) CA1271149A (da)
DE (1) DE3483839D1 (da)
DK (1) DK174081B1 (da)
ES (1) ES529023A0 (da)
IE (1) IE56716B1 (da)
MY (1) MY101958A (da)
ZA (1) ZA84375B (da)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4713339A (en) * 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
AU2353384A (en) * 1983-01-19 1984-07-26 Genentech Inc. Amplification in eukaryotic host cells
NZ210501A (en) * 1983-12-13 1991-08-27 Kirin Amgen Inc Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
KR850004274A (ko) * 1983-12-13 1985-07-11 원본미기재 에리트로포이에틴의 제조방법
US4703008A (en) * 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
GB8415186D0 (en) * 1984-06-14 1984-07-18 Ciba Geigy Ag Polypeptides
EP0174835A1 (en) * 1984-09-11 1986-03-19 The Upjohn Company Human tissue plasminogen activator and recombinant DNA compounds
EP0178105B1 (en) * 1984-10-01 1997-04-02 Genzyme Corporation Recombinant DNA techniques and the products thereof
GR860875B (en) * 1985-04-04 1986-07-29 Beecham Group Plc Novel compounds
US5672502A (en) * 1985-06-28 1997-09-30 Celltech Therapeutics Limited Animal cell culture
AU593264B2 (en) * 1985-07-10 1990-02-08 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Chromosomal DNA sequence, expression vector for human tissue plasminogen activating factor, cultured cells transfected with same and method of producing said activating factor
NZ217331A (en) * 1985-08-26 1989-05-29 Lilly Co Eli Tissue plasminogen activator derivatives and genetically engineered product
GB8528321D0 (en) * 1985-11-18 1985-12-24 Ciba Geigy Ag Modified fibrinolytic agents
JPH0714341B2 (ja) * 1985-11-20 1995-02-22 鐘淵化学工業株式会社 蛋白質の高生産株の取得方法
US4927630A (en) * 1986-02-26 1990-05-22 Monsanto Company Tissue plasminogen activator from normal human colon cells
US4751084A (en) * 1986-02-26 1988-06-14 Monsanto Company Tissue plasminogen activator from normal human colon cells
US5132214A (en) * 1986-04-09 1992-07-21 Monsanto Company Large scale production of plasminogen activator from normal human colon cells
US4851517A (en) * 1986-02-26 1989-07-25 Monsanto Company Tissue plasminogen activator oligosaccharide from normal human colon cells
CA1297434C (en) * 1986-04-14 1992-03-17 Kenji Murakami Method of producing peptides, recombinant plasmid for use in the same and animal cells transformed with the same
JP2585532B2 (ja) * 1986-05-10 1997-02-26 三井東圧化学株式会社 動物細胞の形質転換体及びそれを得る方法並びにその形質転換体を用いてｔ−ＰＡを生産する方法
JPS62265992A (ja) * 1986-05-12 1987-11-18 Ajinomoto Co Inc ヒト細胞を用いる有用物質の製造方法
PT84991B (pt) * 1986-06-06 1990-03-08 Genentech Inc Processo para a producao de actividador do plasminogenio biologicamente activo
JPS63105675A (ja) * 1986-10-23 1988-05-10 Green Cross Corp:The ヒトウロキナ−ゼの製造方法
PT86162B (pt) * 1986-11-21 1990-11-20 Smithkline Beecham Corp Expressao de proteina recombinante
ZA879286B (en) 1986-12-16 1988-10-26 Smith Kline Rit New plasminogen activators
EP0281246A3 (en) * 1987-02-04 1989-07-12 Invitron Corporation Method to enhance amplification and expression of foreign genes
NZ219516A (en) * 1987-02-10 1991-02-26 Wellcome Found Fusion proteins of hbcag (hepatitis b virus core antigen)
US5013653A (en) * 1987-03-20 1991-05-07 Creative Biomolecules, Inc. Product and process for introduction of a hinge region into a fusion protein to facilitate cleavage
US5215896A (en) * 1987-03-20 1993-06-01 Creative Biomolecules, Inc. Leader sequences for the production of recombinant proteins
US5681713A (en) * 1987-05-08 1997-10-28 Smithkline Beecham Corporation Expression of heterologous proteins in Drosophila cells
CA1341345C (en) * 1987-05-08 2002-03-05 Hanne Ranch Johansen Expression of foreign genes in drosophila cells
US4873316A (en) * 1987-06-23 1989-10-10 Biogen, Inc. Isolation of exogenous recombinant proteins from the milk of transgenic mammals
US5017478A (en) * 1987-07-16 1991-05-21 Berlex Laboratories, Inc. Transfected cells containing plasmids having genes oriented in opposing directions and methods of using
EP0322049B1 (en) * 1987-12-21 1993-04-07 Unilever N.V. Nickel/silica catalysts and their preparation
EP0555203B1 (en) * 1988-12-08 1995-10-18 Abbott Laboratories Expression induction method employing dhfr gene
US5641670A (en) * 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
US5733761A (en) * 1991-11-05 1998-03-31 Transkaryotic Therapies, Inc. Protein production and protein delivery
TW402639B (en) * 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
EP2258843B1 (en) 2008-02-27 2016-11-16 National University Corporation Hokkaido University Expression vector for mass production of foreign gene-derived protein using animal cell and use thereof
CN102325881B (zh) 2008-12-22 2014-08-20 国立大学法人北海道大学 用于用动物细胞大量生产源自外源基因的蛋白质的表达载体及其应用
HRP20200768T4 (hr) 2009-08-11 2025-03-28 F. Hoffmann - La Roche Ag Proizvodnja proteina u mediju za uzgoj stanica bez glutamina
RU2500817C1 (ru) * 2012-07-19 2013-12-10 Общество с ограниченной ответственностью "Международный биотехнологический центр "Генериум" ("МБЦ "Генериум") РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК рВК415, КОДИРУЮЩАЯ ПОЛИПЕПТИД РЕКОМБИНАНТНОГО ТКАНЕВОГО АКТИВАТОРА ПЛАЗМИНОГЕНА ЧЕЛОВЕКА, ЛИНИЯ КЛЕТОК Cricetulus griseus CHO 1F8 - ПРОДУЦЕНТ РЕКОМБИНАНТНОГО ТКАНЕВОГО АКТИВАТОРА ПЛАЗМИНОГЕНА ЧЕЛОВЕКА И СПОСОБ ПОЛУЧЕНИЯ И ВЫДЕЛЕНИЯ ПОЛИПЕПТИДА, ОБЛАДАЮЩЕГО АКТИВНОСТЬЮ ТКАНЕВОГО АКТИВАТОРА ПЛАЗМИНОГЕНА
PL3137595T3 (pl) 2014-04-29 2019-09-30 Novartis Ag Nowe komórki kręgowców i sposoby ekspresji rekombinowanej polipeptydu będącego przedmiotem zainteresowania
US11781146B2 (en) 2018-05-24 2023-10-10 National University Corporation Hokkaido University Vector including a translation-impaired dihydrofolate reductase gene cassette and ubiquitously acting chromatin opening element

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370417A (en) * 1980-04-03 1983-01-25 Abbott Laboratories Recombinant deoxyribonucleic acid which codes for plasminogen activator
JPS5879205A (ja) * 1981-11-06 1983-05-13 Canon Inc 色分解用フイルタ−の製造方法
GR79202B (da) * 1982-05-05 1984-10-22 Genentech Inc
AU2353384A (en) * 1983-01-19 1984-07-26 Genentech Inc. Amplification in eukaryotic host cells
JPS61185427A (ja) * 1985-02-13 1986-08-19 Toyoda Gosei Co Ltd 射出装置
JPS6423654A (en) * 1987-07-17 1989-01-26 Fujitsu Ltd Pre-emphasis circuit

Also Published As

Publication number Publication date
AU2353484A (en) 1984-07-26
DK21184A (da) 1984-08-24
ATE59410T1 (de) 1991-01-15
ES8507610A1 (es) 1985-10-01
ZA84375B (en) 1985-02-27
IE56716B1 (en) 1991-11-20
DK174081B1 (da) 2002-05-27
ES529023A0 (es) 1985-10-01
EP0117059A2 (en) 1984-08-29
IE840097L (en) 1984-07-19
KR840007255A (ko) 1984-12-06
MY101958A (en) 1992-02-15
EP0117059A3 (en) 1986-03-05
EP0117059B1 (en) 1990-12-27
JPS59183693A (ja) 1984-10-18
CA1271149A (en) 1990-07-03
DE3483839D1 (de) 1991-02-07
AU572108B2 (en) 1988-05-05

Similar Documents

Publication Publication Date Title
DK21184D0 (da) Fremgangsmade til fremstilling af human vaevsplasminogenaktivator (tpa) i vaertsceller,udtrykkelsesvektor for tpa og et dhfr-protein,celler transformeret med vektoren,og fremgangsmade til foroegelse af vaertscellernes produktion af tpa
NO871816L (no) Superoksid dismutase og fremgangsmaate til dens fremstilling.
DK312387D0 (da) Humane tumor tnf polypeptidmutanter, deres fremstilling og dna, kodende disse
HUT56884A (en) Process for producing protein having urate oxidase activity, gene coding for it, expression vector, microorganisms and transformed cells
DE3778758D1 (de) Verfahren zur herstellung von biologisch aktivem plasminogenaktivator.
DE68926569D1 (de) Cho-zellen befähigt enzymatisch aktive rekombinante-glukocerebrosidase zu produzieren
GR3003301T3 (en) Process for improving the expression of a eucaryotic protein
HUT42524A (en) Process for the enhancement of the production of t-pa and scu-pa
UY25097A1 (es) Proceso para la produccion de heparina
DE69328992D1 (de) Mutanten von menschlichem Antithrombin III
FI98219B (fi) Menetelmä urokinaasityyppisen plasminogeenin aktivaattorin tuottamiseksi
NO175872C (no) Plasmidvektor, fremgangsmåte for fremstilling av peptider og myelomcelle
Cini et al. Molecular basis of the isozymes of bovine glucose-6-phosphate isomerase
NZ298801A (en) Thrombolytic agent from Staphlococcus aureus
EP0227102A3 (en) Cell line established from human normal uterine muscle, method for producing plasminogen activator using the cell line, and plasminogen activator
FI894657A0 (fi) Menetelmä ihmiskudostyyppisen plasminogeeniaktivaattorin tuottamiseksi
SE9300509D0 (sv) Peg treatment
EP0232544A3 (en) Process for producing physiologically active substances
JPS6427472A (en) Production of human tissue plasminogen activator and cell strain using therein
Levinson et al. Human TPA production using vectors coding for DHFR protein
JPS5794290A (en) Method for producing interferon
ES2013184A6 (es) Un procemiento para producir un activador de plasminogeno de tipo tejido (t-pa) mejorado.

Legal Events

Date Code Title Description
PUP Patent expired